Hoth Therapeutics Awarded Key US Patent for Groundbreaking Alzheimer’s Treatment and Prepares for Clinical Trials of HT-ALZ with Formulation Now Underway

Posted on by

NEW YORK, Oct. 15, 2024 /PRNewswire/ — Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company focused on developing innovative treatments, is proud to announce the granting of a U.S. patent for its pioneering Alzheimer’s treatment, HT-ALZ. This milestone…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.